STAT July 15, 2024
Medicare’s new guidelines cover how it will conduct the drug price negotiations authorized by the Inflation Reduction Act. Unfortunately, the Centers for Medicare and Medicaid Services is interpreting the law in a way that will discourage companies from finding new uses — sometimes lifesaving new uses — for existing drugs. It will also deter companies from doing research on existing medicines to create improved versions that are more effective and have fewer side effects.
Yet these new versions may be less costly, as well as easier for patients to take and for health professionals to administer. For example, a new version may make it possible to take a pill instead of an injection or take medicine at home instead of...
Today's Sponsors
Today's Sponsor